Industrial Technology Research Institute

I-Huang Lu

I-Horng Pan

Zong-Keng Kuo

Chu-Hsun Lu

Kuo-Kuei Huang

I-Hong Pan

Jir-Mehng Lo

Shu-Fang Wen

Hsin-Chieh Wu

Hsin-Jan Yao

Yi-Cheng Cheng

Pei-Hsin Lin

Tien-Soung Tong

Meng-Nan Lin

Shu-Jiau Chiou

Ying-Fei Tsai

Der-Yuan Chen

Ming-Han Li

Hsiang-Wen Tseng

Mei-Wei Lin

Chi-Chien Lin

Ching-Huai Ko

Ching Te Lu

Shyh-Horng Lin

Ya-Yan Yang

Jia-Horng Liaw

Chun-Chung Wang

Joung-Liang Lan

Tze-Chung Lee

Tze- Chung Lee

A method for treating an autoimmune neurological disease and/or a neurodegenerative disease is provided. The method includes administering an effective amount of at least one compound having Formula (I), Formula (II) or Formula (III), or its geometric isomer, enantiomer or diastereomer to a subject in need thereof: whereinis a single or double bond, X is NCHor CH, Y is null, O or N, Z is O or N, Ris H, OH, and Ris null, H, C-Calkyl, &#x2014;(C&#x2550;O)-alkyl, &#x2014;(C&#x2550;O)-aryl, &#x2014;(C&#x2550;O)-alkyl-aryl, &#x2014;(C&#x2550;O)-heteroaryl, cycloalkyl or heterocycloalkyl, which optionally substituted by one or more of &#x2014;OH, &#x2014;NO, &#x2014;NH, &#x2014;NRR, carbonyl, alkoxyl, alkyl or &#x2014;OCF, wherein Rand Rindependently are H, alkyl, &#x2014;SOCH, &#x2014;(C&#x2550;O)&#x2014;CHor &#x2014;(C&#x2550;O)&#x2014;NH.

Method for treating an autoimmune neurological disease and/or neurodegenerative disease and pharmaceutical formulations for a liquid dosage form and a controlled release dosage form

The present disclosure provides a pharmaceutical composition for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis, including: an effective amount of an extract of a plant belonging toas an effective ingredient for treating or alleviating the autoimmune disease and/or complication thereof and/or nephritis, wherein the autoimmune disease is selected from a group consisting of lupus erythematosus, psoriasis, psoriatic arthritis, ankylosing spondylitis, rheumatoid arthritis, juvenile idiopathic arthritis, Crohn's disease and ulcerative colitis (UC).

Pharmaceutical composition for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis and method for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis

The disclosure provides a pharmaceutical composition for inhibiting angiogenesis, including an effective amount of an extract ofor an effective amount of a lignan as an effective ingredient. The pharmaceutical composition may further include a pharmaceutically acceptable carrier or salt. The disclosure also provides a method for inhibiting angiogenesis, including administering an effective amount of an extract ofor an effective amount of a lignan as an effective ingredient for inhibiting angiogenesis to a subject in need thereof.

Pharmaceutical compositions and method for inhibiting angiogenesis

The disclosure provides a method for modulating Th17 cells, including: administering an(also namedor) extract to a subject in need thereof, wherein theextract has an effect of modulating Th17 cells. Theextract may include a fruiting body extract ofor a mycelium extract of

Method for modulating Th17 cells and method for treating a disease related to modulation of Th17 cells

Growing community of inventors

Taipei, Taiwan

I-Huang Lu